tradingkey.logo
搜索

Upexi Inc

UPXI
添加自选
0.994USD
-0.041-3.96%
收盘 09-10 16:00美东
66.43M总市值
亏损市盈率 TTM
盘后交易  (美东)0.000USD0.000

关于 Upexi Inc 公司

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Upexi Inc 简介

公司代码UPXI
公司名称Upexi Inc
上市日期Jun 24, 2021
CEOMarshall (Allan)
员工数量59
证券类型Ordinary Share
年结日Jun 24
公司地址3030 Rocky Point Drive
城市TAMPA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33607
电话17013535425
网址https://upexi.com/
公司代码UPXI
上市日期Jun 24, 2021
CEOMarshall (Allan)

Upexi Inc公司高管

名称
名称/职务
职务
持股
持股变动
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Brian Rudick
Mr. Brian Rudick
Chief Strategy Officer
Chief Strategy Officer
938.60K
+42.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
459.14K
+87.12%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
459.14K
+87.12%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
75.00K
-33.33%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
75.00K
-33.33%
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Brian Rudick
Mr. Brian Rudick
Chief Strategy Officer
Chief Strategy Officer
938.60K
+42.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
459.14K
+87.12%

常见问题

Upexi Inc的前五大股东是谁?

Upexi Inc 的前五大股东如下: Allan Marshall ,

有多少机构持有Upexi Inc(UPXI)的股份?

截至2026Q1,共有122家机构持有Upexi Inc的股份,合计持有的股份价值约为23.05M,占公司总股份的34.45%。与2025Q4相比,机构持股有所增加,增幅为-188428.00。

哪个业务部门对Upexi Inc的收入贡献最大?

在2026Q1,Contract manufactured业务部门对Upexi Inc的收入贡献最大,创收744.32K,占总收入的70.84%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有